Company overview
Basic information
Company name
Gaisro sprendimai, MB
Company code
307386625
VAT code
LT100019523212
Registered address
Vilnius, V. Nagevičiaus g. 3, LT-08237
Registration date
2025-08-12
Company age: 1 y. 2 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Other specialised design activities
Ownership form
Private without foreign capital
MB "Gaisro sprendimai"
Company code: 307386625
Address: Vilnius, V. Nagevičiaus g. 3, LT-08237
VAT code: LT100019523212
Description
This description was generated by artificial intelligence.
Gaisro sprendimai, MB (company code 307386625) is an operational private small partnership registered on 12 August 2025. It is based in Vilnius, Vilniaus m. municipality, Vilniaus county, at V. Nageviciaus g. 3, LT-08237. The company belongs to the national private non-financial companies sector and is organised under a CEO-only governance model. Its ownership is private, with more than 50% of authorised capital owned by Lithuanian natural and legal persons and no foreign investor capital. The company is classified as a micro enterprise. Its main activity is listed under EVRK N.74.14.00, Other specialised design activities. Financially, the company reported revenue of EUR 22.3 thousand and net profit of EUR 21.0 thousand for its 2025 financial year, which covered 141 days. This corresponds to a profit margin of 94.3%. At year-end 2025, equity stood at EUR 12.9 thousand, total assets at EUR 10.1 thousand, and liabilities at EUR 134. The available figures indicate a very small balance sheet and limited leverage in its first reported financial period.
Download a detailed company report
Make confident decisions with all the information about Gaisro sprendimai, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.